...2021 and May 2025. That didn’t prevent Chinese regulators from greenlighting a generic saxagliptin from Jiangsu Aosaikang Pharmaceutical Co. Ltd....

...month, Living Cell said it was in negotiations to enter a research collaboration which proposes Jiangsu Aosaikang Pharmaceutical Co. Ltd....

...exchange for 14.3 million Living Cell shares, which represents a 4.7% stake in the company. Jiangsu Aosaikang Pharmaceutical Co. Ltd....

...A$1.7 million (US$1.7 million) Shares: 14.3 million Price: A$0.12 Shares after offering: 304.7 million Investors: Jiangsu Aosaikang Pharmaceutical Co. Ltd. WIR...

...and ovarian cancer are planned to begin this year. Access Pharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Jiangsu Aosaikang Pharmaceutical Co. Ltd....